Visibly Clean Hand Sanitizer (2020-06-18)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73407r-eng.php
Autoridades clausuran 9 empresas agrícolas
Miércoles 17 de junio, 2020. Mediante un video reproducido en conferencia de prensa este mediodía, el ministro Soto Rojas detalló que se abordaron en total 1.967 personas de las cuales 1.405 son nacionales y 466 extranjeros.
1871 casos confirmados por COVID-19
Miércoles 17 de junio, 2020. Al 17 de junio se registran 75 nuevos casos de COVID-19, para un total de 1871 casos confirmados, con un rango de edad de cero a 92 años.
Recall of certain hand sanitizers that may pose health risks
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73385a-eng.php
Uso de la luz ultravioleta para la desinfección de ambientes o superficies hospitalarias en el contexto de SARS-CoV-2
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1100100
Dexametasona no previene el COVID-19
Martes 16 de junio, 2020. Autoridades de Salud indicaron que la dexametasona no debe utilizarse como medicamento preventivo, ni como tratamiento en las fases iniciales de la enfermedad por COVID-19. Además subrayaron que este medicamento solo debe ser administrado bajo una indicación médica.
Alerta naranja se prorroga una semana más en algunos distritos
Martes 16 de junio, 2020. Los distritos de Pococí, Peñas Blancas (San Ramón), Los Chiles (Los Chiles), La Fortuna (San Carlos), Upala y Paquera (Puntarenas)…
WHO has a public consultation on the following document for the WHO Expert Committee on Biological Standardization (ECBS) is now open.
WHO assessment and accelerated national registration of WHO-prequalified In Vitro Diagnostics (IVDs)
The 1st draft of the Collaborative procedure between the World Health Organization (WHO) and National Regulatory Authorities in the assessment and accelerated national registration of WHO-prequalified In Vitro Diagnostics (IVDs) has been prepared to enhance timely access to WHO-prequalified products in countries, to ensure that the product in countries is the same as the one which is WHO-prequalified and to provide a model for regulatory information exchange between countries. The draft document has been updated based on the informal consultation with experts from the National Regulatory Authorities which was conducted in November 2019 during the WHO Workshop on Collaborative Registration Procedure for Diagnostics.
WHO are now publishing this draft to get the feedback from a broad audience of relevant government authorities, manufacturers, and other experts. DEADLINE for submission of comment: 15 July 2020. Please send comments to: gunlud@who.int.
You could download the document directly by clicking on the following link: https://www.who.int/biologicals/Collaborative_Procedure_for_IVDs_for_PC.pdf?ua=1
In order to provide your comments, please use the template, https://www.who.int/biologicals/Comment_Form_CRP_diagnostics_June_2020.doc?ua=1
